F-Prime Capital
Investor profile
F-Prime Capital has backed 12 European tech companies across 15 funding rounds between 2016 and 2026, joining rounds totalling €679M. Most active in Healthtech and AI. Data as of Nov 2026.
Also recorded as: F Prime Capital · F-Prime Capital Partners
Deals
15
distinct rounds
Companies
12
backed
Active span
2016–2026
11 yrs
Total round €
€679M
sum of rounds joined
Deals by year
distinct rounds / yearF-Prime Capital — deals by year — interactive chart.
Data table
| F-Prime Capital — deals by year | |
|---|---|
| 2016 | 1 |
| 2017 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Top sectors
by dealsF-Prime Capital — top sectors — interactive chart.
Data table
| F-Prime Capital — top sectors | |
|---|---|
| Healthtech | 7 |
| AI | 2 |
| Fintech | 2 |
| Travel | 2 |
| Software | 1 |
| Cybersecurity | 1 |
| Marketing | 1 |
Stages
by dealsF-Prime Capital — stages — interactive chart.
Data table
| F-Prime Capital — stages | |
|---|---|
| Series B | 6 |
| Other | 5 |
| Early VC | 1 |
| Pre-Seed | 1 |
| Series A | 1 |
| Series C | 1 |
Countries
by dealsF-Prime Capital — countries — interactive chart.
Data table
| F-Prime Capital — countries | |
|---|---|
| UK | 9 |
| Netherlands | 2 |
| Sweden | 2 |
| Italy | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Eight Roads Ventures7
- AlbionVC2
- Khosla Ventures2
- OrbiMed2
- SR One2
- and Walking Ventures.1
- AP41
- Arrington Capital1
- Axial1
- Balderton Capital1
- Bessemer Venture Partners1
- BitRock Capital1
- Bluebird Ventures1
- Braavos Capital1
- Brainchild1
- Byers Capital1
- Casdin Capital1
- CMT Digital1
- dRX Capital1
- Earlybird Venture Capital1
- Exponential Science Foundation1
- First Round Capital1
- Fulgur Ventures1
- FundersClub1
- General Catalyst1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Leyden Labs | Netherlands | 1 | €124M |
| Charm Therapeutics | UK | 2 | €116M |
| Ota Insight | UK | 2 | €89M |
| Oviva | UK | 2 | €79M |
| Funnel | Sweden | 1 | €57M |
| Hercle | Italy | 1 | €52M |
| Castor | Netherlands | 1 | €38M |
| Peptone | UK | 1 | €37M |
| Proximie | UK | 1 | €32M |
| Pulmocide | UK | 1 | €28M |
| STS Digital | Switzerland | 1 | €25M |
| Castle | Sweden | 1 | €1.8M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Leyden Labs | Series B | €124M | 2022-01 |
| Ota Insight | Series B | €71M | 2021-11 |
| Charm Therapeutics | Series B | €69M | 2025-09 |
| Oviva | Series C | €68M | 2021-09 |
| Funnel | Pre-Seed | €57M | 2021-10 |
| Hercle | Other | €52M | 2025-10 |
| Charm Therapeutics | Series A | €47M | 2022-06 |
| Castor | Series B | €38M | 2021-07 |
| Peptone | Other | €37M | 2022-06 |
| Proximie | Series B | €32M | 2021-04 |